Company intelligence / Profile preview

Avinger

Redwood City, California, United Statesavinger.com ↗
Ownership
Public · AVGR
Employees
~100
Development stage
Commercial
01

Overview

Avinger has commercialized the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of PAD. Its Pantheris device demonstrated safety and efficacy in the INSIGHT trial for treating in-stent restenosis. The company is developing a new image-guided CTO-crossing system targeting coronary artery disease, with an FDA pre-submission package filed and IDE application planned.[3][6]

Therapeutic areas
Cardiovascular
Modalities
Image-guided catheter-based systemsOptical Coherence Tomography (OCT)-guided devicesAtherectomy devices for vascular disease treatment[3][6][8]
Industry
Medical Imaging
02

Drug pipeline

4 assets

Lightbox

Commercial
Indications
Peripheral artery disease, Coronary artery disease

3 more assets in the full pipeline.

Request access →
03

Partnerships

No major pharmaceutical or biotech partnerships disclosed as of latest reports.
04

Financials

Market cap
$1.5M
Total revenue
$1.7M
Enterprise value
$1.2M

Beyond the preview

Go deeper on Avinger.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Avinger.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call